Healthcare is entering a new era where Artificial Intelligence can enable earlier detection, predictive diagnosis, and more personalized treatment outcomes. Yet, despite rapid progress in AI models, real-world adoption remains constrained by fragmented data systems, compliance challenges, and trust gaps within clinical environments. Building scalable, secure, and interoperable infrastructure is becoming just as important as algorithmic innovation itself. In this exclusive conversation, Rajeev Ranjan, Editor, Digital Terminal speaks with Gunjan Ramteke, Partner Development Manager, Amazon Web Services (AWS) and Independent Researcher, about healthcare AI adoption barriers, federated learning, uncertainty-aware diagnostics, and the future of precision medicine globally.
Rajeev: Why is early disease detection limited more by infrastructure than AI models?
Gunjan: The models are ready. The ecosystems are not. Most healthcare systems still run on fragmented data silos, legacy EHR infrastructure, and disconnected diagnostic pipelines. Even a highly accurate AI model becomes useless if it cannot access clean, interoperable patient data at the point of care. Having worked at the intersection of cloud architecture and clinical AI research, I have seen firsthand that the real bottleneck is not algorithmic. It is the absence of scalable, secure, and standards-compliant data infrastructure that can actually operationalize these models in real-world settings.
Rajeev: What barriers prevent your HCV detection model from scaling into clinical deployment?
Gunjan: Our HCVTransFuse model achieved over 97% accuracy in controlled research settings, but moving into clinical deployment surfaces a completely different class of challenges. Regulatory pathways like FDA 510(k) or CE marking are lengthy and demand validation across diverse patient populations. Beyond compliance, there is the problem of model drift. A model trained on one hospital's data may simply underperform in a different geography or demographic. And clinician trust is honestly an underrated barrier. Physicians need explainability, not just accuracy numbers, before they are willing to act on an AI recommendation.
Rajeev: How does AI enable a shift from reactive to predictive healthcare?
Gunjan: Healthcare has always been built around treating disease after it shows up. AI changes that. With early screening frameworks that pull from imaging, lab markers, and genomics together, we can start identifying disease signatures years before any clinical symptoms appear. In my research on liver disease and cancer, I have seen how deep learning architectures can pick up on subtle biomarker patterns that even experienced clinicians might miss at early stages. The shift to predictive care is not some distant future thing. It is a deployment and adoption problem we need to solve right now.
Rajeev: How important are uncertainty-aware systems for patient safety?
Gunjan: They are critically important, and this is something I feel strongly about. An overconfident AI is arguably more dangerous than no AI at all in a clinical setting. When a model predicts with high confidence but gives no signal that it is operating outside its training distribution, you risk serious misdiagnosis. My work on Bayesian uncertainty quantification through the UncertainNet framework is built around exactly this concern. Every prediction should carry a calibrated confidence estimate. Clinicians deserve to know not just what the model thinks, but how certain it actually is. That is what trustworthy clinical AI looks like.
Rajeev: How can federated learning address data fragmentation and trust challenges?
Gunjan: Federated learning is one of the most practical solutions we have for scaling healthcare AI responsibly. Instead of centralizing sensitive patient data, which raises serious HIPAA, GDPR, and institutional trust concerns, federated approaches let models train locally at each hospital and share only encrypted model gradients. My FedFusion framework explores this for multi-institutional liver disease detection. It preserves patient privacy while still enabling collaborative model improvement across different geographies. Combined with differential privacy and secure aggregation, federated learning makes interoperability genuinely achievable without putting data sovereignty at risk.
Rajeev: How will multi-omics integration and agentic AI shape the future of diagnostics?
Gunjan: The next step is context-aware diagnostic intelligence that can actually reason and act. Multi-omics integration, which brings together genomic, proteomic, transcriptomic, and clinical data, gives AI a much richer signal than any single data type alone. When you layer agentic AI on top of that, systems that can reason, retrieve, and work across complex data pipelines without needing constant human instruction, you get something genuinely different. AI that does not just flag a risk but helps coordinate the next diagnostic step. That is the direction my research is heading, and I think it will meaningfully reshape precision medicine within this decade.
𝐒𝐭𝐚𝐲 𝐢𝐧𝐟𝐨𝐫𝐦𝐞𝐝 𝐰𝐢𝐭𝐡 𝐨𝐮𝐫 𝐥𝐚𝐭𝐞𝐬𝐭 𝐮𝐩𝐝𝐚𝐭𝐞𝐬 𝐛𝐲 𝐣𝐨𝐢𝐧𝐢𝐧𝐠 𝐭𝐡𝐞 WhatsApp Channel now! 👈📲
𝑭𝒐𝒍𝒍𝒐𝒘 𝑶𝒖𝒓 𝑺𝒐𝒄𝒊𝒂𝒍 𝑴𝒆𝒅𝒊𝒂 𝑷𝒂𝒈𝒆𝐬 👉 Facebook, LinkedIn, Twitter, Instagram